David Anderson

Hepatic Drug Targeting: Phase I Evaluation of Polymer-Bound Doxorubicin

Leonard W. Seymour, David Ferry, David Anderson et al. · Journal of Clinical Oncology · 2002 · 284 citations

Pharmacy, Oncology, Pharmacology +16

Pre-clinical and clinical study of QC12, a water-soluble, pro-drug of quercetin

Paul Mulholland, D. Ferry, David Anderson et al. · Annals of Oncology · 2001 · 159 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +4

Characterization of the human liver vasopressin receptor. Profound differences between human and rat vasopressin-receptor-mediated responses suggest only a minor role for vasopressin in regulating human hepatic function

John Howl, Tariq Ismail, Alastair J. Strain et al. · Biochemical Journal · 1991 · 66 citations · Full text

Medicine, Pharmacology, Physiology +16

Dual infection with hepatitis A and E viruses in outbreaks and in sporadic clinical cases: Cuba 1998–2003

Licel de los Ángeles Rodríguez Lay, Ariel Quintana, María Caridad Montalvo Villalba et al. · Journal of Medical Virology · 2008 · 49 citations

Veterinary Medicine, Infectious Diseases, Microbiology +12

EVALUATION OF A NEW RAPID IMMUNOCHROMATOGRAPHIC ASSAY FOR SERODIAGNOSIS OF ACUTE HEPATITIS E INFECTION

Khin Saw Aye Myint, Ming Guan, Hsiao Ying Chen et al. · American Journal of Tropical Medicine and Hygiene · 2005 · 44 citations

Life Sciences, Immunology, Infectious Diseases +16